Skip to main content
Official EU label nameGlossary entry 29829

VERBASCOSIDE

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence
Markets checked
13
Markets with evidence
0
Evidence gaps
13
Resolved identifiers
1

Resolved substance identity

CAS:61276-17-3
Ingredient index records:
VERBASCOSIDE
Cosmetic functions: ANTIOXIDANT, BLEACHING, CHELATING, SKIN PROTECTING

Glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl 3-O-(6-deoxy-α-L- mannopyranosyl)-, 4-(3-(3,4-dihydroxyphenyl)-2-propenoate), (E)-β- D-

1 matched or reported name
VERBASCOSIDE

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name VERBASCOSIDE.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Chemical identity and properties

PubChem 2D chemical structure for CAS 61276-17-3
CAS 61276-17-3PubChem CID 5281800

Verbascoside

Acteoside is a glycoside that is the alpha-L-rhamnosyl-(13)-beta-D-glucoside of hydroxytyrosol in which the hydroxy group at position 4 of the glucopyranosyl moiety has undergone esterification by formal condensation with trans-caffeic acid. It has a role as an antibacterial agent, a neuroprotective agent, an anti-inflammatory agent, an antileishmanial agent and a plant metabolite. It is a glycoside, a polyphenol, a member of catechols, a cinnamate ester and a disaccharide derivative. It is functionally related to a trans-caffeic acid and a hydroxytyrosol. — ChEBI

IUPAC name
[(2R,3R,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
Molecular formula
C29H36O15
Molecular weight
624.6 g/mol
Exact mass
624.20542044 Da
XLogP3
-0.5
Topological polar surface area
245.0 Ų
Hydrogen-bond donors
9
Hydrogen-bond acceptors
15
Covalent units
1
Defined stereocentres
10

Also known as

ActeosideKusagininTJC 160TJC-1603TGX09BD5BCHEBI:132853NSC-603831beta-D-Glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl 3-O-(6-deoxy-alpha-L-mannopyranosyl)-, 4-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoate]
16 more reported names
beta-D-Glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl 3-O-(6-deoxy-alpha-L-mannopyranosyl)-, 4-((2E)-3-(3,4-dihydroxyphenyl)-2-propenoate)RefChem:510156-(2-(3,4-dihydroxyphenyl)ethoxy)-5-hydroxy-2-(hydroxymethyl)-4-((3,4,5-trihydroxy-6-methyloxan-2-yl)oxy)oxan-3-yl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate612-110-1VerbacosideacetosideNSC 603831cid_24978601C29H36O15CCG-270269UNII-3TGX09BD5BReh-acteosideVerb.BETA.-D-GLUCOPYRANOSIDE, 2-(3,4-DIHYDROXYPHENYL)ETHYL 3-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-, 4-((2E)-3-(3,4-DIHYDROXYPHENYL)-2-PROPENOATE).beta.-D-Glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl 3-O-(6-deoxy-.alpha.-L-mannopyranosyl)-, 4-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoate]2-(3,4-dihydroxyphenyl)ethyl 3-O-(6-deoxy-alpha-L-mannopyranosyl)-4-O-((2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl)-beta-D-glucopyranoside
External database identifiers

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Take this record further

Screen in a formulaOpen standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision